Long-term outcome in pediatric surgical bypass grafting after traumatic injury and tumor resection: retrospective cohort analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 08 2021
Historique:
received: 05 02 2021
accepted: 05 07 2021
entrez: 12 8 2021
pubmed: 13 8 2021
medline: 16 11 2021
Statut: epublish

Résumé

Vascular bypass surgery in children differs significantly from adults. It is a rarely performed procedure in the setting of trauma and tumor surgery. Besides technical challenges to reconstruct the small and spastic vessels, another concern in bypass grafting is the adequate limb length growth over time. The primary aim of this study was to assess long-term outcome after pediatric bypass grafting, in a single academic center, focusing on potential effects on limb development. In this retrospective cohort analyses we included all pediatric patients undergoing vascular bypass grafting at our department between 2002 and 2017. All patients ≤ 18 years suffered a traumatic injury or underwent a tumor resection of the lower or upper limb. The youngest female patient was 0.4 years, the youngest male patient was 3.5 years. During the observation period, 33 pediatric patients underwent vascular repair, whereby 15 patients underwent bypass grafting. Median overall follow-up was 4.7 years (IQR ± 9). 8 patients (53%) had a traumatic injury (traumatic surgery group) and 7 patients had a planned orthopedic tumor resection (orthopedic surgery group). In 13/15 (87%) a great saphenous vein (GSV) graft and in 2/15 (13%) a Gore-Tex graft was used for bypassing. Both Gore-Tex grafts showed complete occlusion 12 and 16 years after implantation. No patient died in the early postoperative phase (< 30 days), however 3/7 (43%) in the orthopedic group died during follow-up. Revision surgery had to be performed in 1/15 (7%) patients. A functional use of the extremity was reported in all patients. Normal limb length growth according to the contralateral site, and therefore bypass growth, could be documented in 14/15 patients. Children are surgically challenging. In our study, surgery by a specialized vascular surgery team using GSV grafts led to adequate limb length and bypass growth, and we observed no functional restrictions.

Identifiants

pubmed: 34381065
doi: 10.1038/s41598-021-94971-2
pii: 10.1038/s41598-021-94971-2
pmc: PMC8357780
doi:

Substances chimiques

Polytetrafluoroethylene 9002-84-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16321

Informations de copyright

© 2021. The Author(s).

Références

J Trauma. 1979 Jul;19(7):532-6
pubmed: 458896
J Vasc Surg. 2001 Jul;34(1):34-40
pubmed: 11436072
J Pediatr Surg. 2007 Jan;42(1):178-82; discussion 182-3
pubmed: 17208561
J Am Coll Surg. 1994 Feb;178(2):155-63
pubmed: 8173726
J Trauma. 2011 Apr;70(4):823-8
pubmed: 21610390
J Surg Oncol. 2007 May 1;95(6):455-60
pubmed: 17458861
J Trauma. 1979 Aug;19(8):551-5
pubmed: 469966
J Vasc Surg. 1992 Sep;16(3):428-35
pubmed: 1522647
Eur J Vasc Endovasc Surg. 2011 Nov;42(5):684-8
pubmed: 21820336
Ann Hum Biol. 2013 Jul;40(4):324-32
pubmed: 23590681
Cochrane Database Syst Rev. 2015 Feb 19;(2):CD000535
pubmed: 25695213
J Trauma Acute Care Surg. 2015 Oct;79(4):563-7
pubmed: 26402529
Angiology. 1976 Jan;27(1):1-7
pubmed: 1053458
J Vasc Surg. 1986 Jan;3(1):104-14
pubmed: 3510323
J Vasc Surg. 2000 Mar;31(3):426-35
pubmed: 10709053
J Trauma Acute Care Surg. 2014 Jun;76(6):1386-9
pubmed: 24854305
J Pediatr Surg. 2016 Nov;51(11):1885-1890
pubmed: 27497495
J Vasc Surg. 2006 Nov;44(5):1046-50
pubmed: 17098540
Ann Surg. 2015 Oct;262(4):632-40
pubmed: 26366542
J Vasc Surg. 2019 Mar;69(3):857-862
pubmed: 30292605
J Vasc Surg. 2014 Aug;60(2):443-7
pubmed: 24801554
Perspect Vasc Surg Endovasc Ther. 2011 Jun;23(2):100-10
pubmed: 21810814
J Orthop Surg Res. 2010 Apr 15;5:25
pubmed: 20398337
Pediatr Surg Int. 2007 Jan;23(1):1-10
pubmed: 17004094
Surgery. 1981 Jul;90(1):20-31
pubmed: 7245048
Ulus Travma Acil Cerrahi Derg. 2017 May;23(3):217-222
pubmed: 28530775
Rev Bras Ortop. 2017 Oct 21;52(6):714-719
pubmed: 29234656
Eur J Vasc Endovasc Surg. 2006 Dec;32(6):690-5
pubmed: 16872850
J Craniofac Surg. 2012 Jul;23(4):1140-2
pubmed: 22777466
J Pediatr Surg. 2010 Jul;45(7):1404-12
pubmed: 20638516
Arch Surg. 1976 Nov;111(11):1269-75
pubmed: 985076

Auteurs

Stephanie Kampf (S)

Division of Vascular Surgery, Department of Surgery, Medical University Vienna, Vienna, Austria.

Madeleine Willegger (M)

Department of Orthopedics and Trauma-Surgery, Medical University of Vienna, Vienna, Austria.

Christopher Dawoud (C)

Division of Vascular Surgery, Department of Surgery, Medical University Vienna, Vienna, Austria.

Gerhard Fülöp (G)

Austrian Public Health Institute, Gesundheit Österreich GmbH, Vienna, Austria.

Philipp Lirk (P)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Andrea Willfort-Ehringer (A)

Division of Angiology, Department of Internal Medicine, Medical University of Vienna, Vienna, Austria.

Christoph Neumayer (C)

Division of Vascular Surgery, Department of Surgery, Medical University Vienna, Vienna, Austria.

Bernd Gollackner (B)

Division of Vascular Surgery, Department of Surgery, Medical University Vienna, Vienna, Austria. bernd.gollackner@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH